Prolonged Efficacy and Safety of a Drug-Eluting Resorbable Scaffold in CLTI: Three-Year Outcomes and Subgroup Analyses From the LIFE-BTK Trial
Location: Lafite Ballroom
Speaker: Sahil A. Parikh, MD – New York Presbyterian/Columbia University Irving Medical Center
Global Theater
Monday, Nov 3rd
11:00am - 11:15am PT
One-Year Outcomes From the Disrupt PAD BTK II Study: Treatment of Patients With Calcified Below-the-Knee Lesions With a Peripheral Intravascular Lithotripsy System
STRIKE-PE: One-Year Functional Outcomes and Quality of Life in Pulmonary Embolism Patients Treated With Computer Assisted Vacuum Thrombectomy Using the 16F Catheter System
Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk PE: Primary Outcome, Functional Endpoints, and Core Lab Findings From STORM-PE
Potential for Sustained Abdominal Aortic Aneurysm Growth Stabilization After a Single Intra-Aortic Administration of Pentagalloylglucose: Clinical Evidence From a Phase I Study With the Nectero EAST® System
MOTIV BTK RCT: Safety & Effectiveness Study of the MOTIV Sirolimus-Eluting Bioresorbable Coronary Scaffold Compared with Plain Balloon Angioplasty for the Treatment of Infrapopliteal Lesions–Primary Safety Endpoint
One-Year Outcomes From the FORWARD PAD IDE and Feasibility Studies of the Treatment of Calcified PAD With a Novel Forward Peripheral Intravascular Lithotripsy System
36-Month Performance of a Sirolimus-Eluting Balloon in Diabetic and Nondiabetic Patients With Femoropopliteal Artery Disease From the SELUTION SFA Japan Study